Which U.S. Sunscreens Will Have Bemotrizinol First, and What to Look For on the Label The Wait Is Almost Over With the FDA’s June 9, 2026 approval of bemotrizinol, the first new sunscreen active ingredient approved in the United States in more than 25 years, the natural next question from patients is simple: when can [...]
The New Sunscreen Ingredient That Was Blocked for 25 Years, and Why It Matters Most for Skin of Color A 25-Year Photoprotection Deficit When the FDA approved bemotrizinol on June 9, 2026, dermatologists across the country let out a collective exhale. For those of us who specialize in skin of color, treat melasma, counsel patients [...]
Bemotrizinol Is Now FDA-Approved: What It Means for Your Sunscreen The Day American Sunscreen Changed On June 9, 2026, the U.S. Food and Drug Administration approved bemotrizinol, marketed under the brand name PARSOL Shield, as a new active ingredient for sunscreens sold in the United States. This is not a minor regulatory footnote. It is [...]
